Objectives: The aims of this study were to investigate the relationship between sarcopenia, dietary intake, nutritional indices and hip bone mineral density (BMD) in the elderly, and to estimate the risk of low BMD due to specific independent predictor thresholds. Subjects and methods: Body mass index (BMI), serum albumin, energy and protein intake were studied in 352 elderly outpatients (216 women aged 73.575.3 years and 136 men aged 73.975.6 years). BMD at different hip sites and appendicular skeletal muscle mass (ASMM) were assessed by dual-energy X-ray absorptiometry. Results: The prevalence of osteoporosis was 13% in men and 45% in women, while the prevalence of sarcopenia (50%) and hypoalbuminemia (5%) were similar in both genders. BMI, albumin and ASMM were significantly associated with BMD in both genders: so was protein intake, but only in men. By multiple regression analysis, the variables that retained their independent explanatory role on total hip BMD, were BMI and protein intake in men, and BMI and albumin in women. By logistic regression analysis, men risked having a low BMD with a BMI o22 (OR ¼ 12) and a protein intake o65.7 g/day (OR ¼ 3.7). Women carried some risk already in the BMI 25-30 class (OR ¼ 5), and a much greater risk in the BMI o22 class (OR ¼ 26). Albumin o40 g/l also emerged as an independent risk factor (OR ¼ 2.6). Conclusions: BMI in both genders, albumin in women and protein intake in men have an independent effect on BMD. BMI values o22 are normal for younger adults but carry a higher risk of osteoporosis in the elderly, particularly in women. Agerelated sarcopenia does not seem to be involved in bone mass loss.
Introduction
Osteoporosis is a multifactorial condition characterized by low bone mineral density (BMD) and bone architecture deterioration, resulting in a greater risk of fracture, a growing healthcare burden and high social costs (Melton 2003) . Understanding the effect of potentially modifiable lifestyle factors on BMD in the elderly is essential to osteoporosis prevention and treatment; among these factors, sarcopenia and nutritional disorders may have a key role (Ilich et al., 2003) .
Sarcopenia, the physiological decline in muscle mass and function occurring in the elderly, may influence age-related osteoporosis (Russo et al., 2000; Walsh et al., 2006) , since muscle mass and contraction mechanically stimulate the bone mass (Frost, 1987) . The catabolic-inflammatory process underlying sarcopenia might also be associated with bone loss, as in other chronic inflammatory diseases (Bolton et al., 2004) .
Nutritional disorders, and malnutrition in particular, are common in elderly people and might be expected to exacerbate the physiological age-related muscle and bone mass decline (Ilich et al., 2003) . An appropriate approach to investigating the effect of nutrition on BMD includes estimating energy and protein intake and measuring body mass index (BMI) as an indicator of energy malnutrition and serum albumin to identify protein malnutrition. Elderly subjects with a lower protein intake have a greater bone loss, suggesting that protein intake is important in maintaining bone (Hannan et al., 2000) . BMI is widely used in nutritional assessment and several studies have shown that a low BMI is associated with bone loss in elderly men and women (Edelstein and Barrett-Connor 1993; Felson et al., 1993; Nguyen et al 2000) . A low BMI also carries a substantial fracture risk that is largely independent of age or sex, but depends on BMD (De Laet et al., 2005) . Serum albumin is an indicator of protein malnutrition and its depletion reflects a severe protein imbalance that may also affect the bone remodeling process by reducing the production of IGF-1 (Bonjour et al., 1996) . The relationship between serum albumin and BMD is still controversial, however (Di Monaco et al., 2003) .
In the elderly, the effects of undernutrition and sarcopenia overlap in contributing to bone mass loss. In clinical practice, clarifying the independent role of malnutrition and sarcopenia may be of paramount importance for identifying subjects at risk of low BMD, and for implementing timely nutritional and rehabilitation measures (Maddalozzo et al., 2000; Hampson et al., 2003; Walsh et al., 2006) .
The aims of this study were to investigate the relationship between sarcopenia, dietary intake, nutritional indices (BMI, serum albumin) and BMD at different femoral sites, and to estimate the elderly's risk of a low BMD due to specific independent predictor thresholds by comparison with clinically satisfactory levels.
Methods

Subjects
This survey was performed at the Geriatric Units of the Universities of Padova and Verona (Italy) from October 1999 to October 2001. The investigators received the same training for the protocol (exclusion and inclusion criteria, history questionnaire, written informed consent) and the anthropometric and dual-energy X-ray absorptiometry measurements. The sample was recruited from among outpatients who met the following eligibility criteria: stable weight (no body weight fluctuations greater than 5 kg in the previous 6 months), ability to walk at least 800 m without difficulty, no moderate-severe cognitive impairment (MiniMental Status Examination score higher than 21) and no diagnosed or treated osteoporosis.
To rule out any diseases or drugs affecting nutritional status and bone metabolism, a brief history was collected and a physical examination was performed. Subjects with acute diseases, severe liver, heart or kidney dysfunctions, endocrine disorders (diabetes, hypo-or hyper-thyroidism), cancer or other diseases interfering with bone turnover (Paget's, gastroenteropathies with malabsorption, neuromuscular diseases, rheumatic diseases) were excluded. The use of some drugs (steroids, diphenyl hydantoine and heparin) was also a reason for exclusion.
In all, 1153 outpatients were considered and 397 ultimately met the inclusion and exclusion criteria, but 21 refused to take part and 24 did not complete the study protocol, so 352 subjects were effectively recruited, that is, 216 women aged 73.575.3 years, and 136 men aged 73.975.6 years.
Eligible subjects were invited to take part in the study and individual written informed consent was obtained from each participant.
Protocol
Each subject underwent the following tests on the same morning.
Blood tests. A fasting whole-blood test was conducted according to standard methods. All blood samples were drawn in the morning after overnight fasting. Blood samples were centrifuged and plasma and serum were frozen. When all the samples had been collected, they were analyzed at the laboratory in Verona (the samples from Padova were sent to Verona in reliable frozen conditions). Serum albumin was analyzed using a nephelometric method (Behring nephelometric analyzer II, Behring Diagnostics GmbH, Marburg, Germany), with a 2% coefficient of variation. Hypoalbuminemia was conventionally diagnosed at serum albumin values below 35 g/l (Agarwal et al., 1988) and this definition was adopted to obtain a prevalence of this condition among elderly people for comparison with other studies. 25-Hydroxyvitamin D was measured using a radioimmunoassay (RIA) analysis (25 OH DiaSorin Stillwater, MN, USA); the reference range was 37.5-175 nmol/l, coefficient of variation, 8-11%.
Anthropometric measurements. Body weight was measured to the nearest 0.1 kg using a precision scale with subjects wearing light clothing and no shoes (Salus scale, Milan, Italy). Height was measured without shoes and recorded to the nearest millimeter using a stadiometer (Salus stadiometer). Each value was the mean of three consecutive measurements taken by the same operator to minimize intraobserver variation. BMI was calculated as weight divided by height squared (kg/m 2 ). Based on the observation that BMI values below 22 are prognostically unfavorable in the elderly (Allison et al., 1997; Sergi et al., 2005) , BMI was divided into four classes: p22 (underweight); 22-25; 25-30; X30 (overweight) .
Dietary assessment. Information on dietary habits was collected by the means of structured interviews held by trained dieticians. Subjects were asked to indicate their habitual food choices and usual patterns of consumption of the various foodstuffs on a daily, weekly, monthly or yearly basis. This diet assessment method had already been validated in a previous study (Inelmen et al., 2005) and details of the procedure can be found elsewhere (Inelmen et al., 2000) . Mean daily intake was calculated, including total energy (kcal/day), macronutrients (proteins, carbohydrates, lipids) and calcium.
Dual-energy X-ray absorptiometry. Bone mass parameters and lean body mass (LBM) of the limbs were measured using a dual-energy X-ray fan beam densitometer (Hologic QDR 4500 W, at both centers) and dedicated software, rel. 8.2. The NHANES (III) data were used to edit the reference population curve.
BMD, T-score and Z-score at several different hip sites (neck, trochanteris, inter-trochanter region, Ward's triangle, total hip) were measured using standard protocols; repeatability was 1-2% for total hip BMD. The three main femoral sites (trochanter, neck and total hip) were considered in the analysis. No lumbar spine scan was performed because of the potentially confounding effect of spondyloarthrosis (common in the elderly) on BMD. Referring to the WHO Consensus Meeting on Osteoporosis, the definition of osteoporosis was conventionally based on the number of standard deviations (T-score) below the mean BMD of a young adult, gender-specific reference population (WHO, 1994): a T-score oÀ2.5 indicates osteoporosis. The number of standard deviations below the mean BMD of a sex-and age-specific reference population identifies the Z-score.
The LBM of arms and legs was assessed by whole body scan; repeatability was 1-2% for total LBM, 3-4% for arm LBM and 1-2% for leg LBM. The coefficients of variation for the method were assessed by repeated measurements of both phantoms and normal subjects. Appendicular skeletal muscle mass (ASMM) was derived as the sum of arm and leg LBM, as described by Heymsfield (Heymsfield et al., 1990) . The appendicular skeletal muscle mass index (ASMMI) was calculated as the ratio of the ASMM to the square of the person's height in meters. Sarcopenia was diagnosed at ASMMI values two standard deviations below the mean for a healthy young adult population. According to Baumgartner et al.( 1998) , these cutoff points are 7.26 kg/m 2 for men and 5.45 kg/m 2 for women.
Statistical analysis
The quantitative variables were summarized as mean values and standard deviation, by gender. Differences between mean values were assessed with the unpaired t-test. The prevalence of specific conditions was expressed as a percentage, and differences between genders were evaluated using the w 2 -test. Two-way analysis of variance (ANOVA) was used to assess the effects of serum albumin and BMI on total hip BMD, also evaluating the statistical interaction between these two effects. The Pearson product-moment correlation coefficient (r) was used to measure simple linear associations between total hip, trochanter and neck BMD, and age, daily macronutrient intake, total energy intake, daily calcium intake, ASMM, BMI, serum albumin and vitamin D, by gender. Stepwise multiple linear regression was applied to assess the independent association between BMD at different femoral sites and the significantly associated factors emerging from the previous simple linear analysis (that is, age, BMI, daily protein intake, serum albumin and ASMM for men; age, BMI, serum albumin and ASMM for women). Partial and multiple R 2 coefficients were estimated and R 2 was used as a criterion of being fit. To test for multicollinearity, a variance inflation factor was computed for each independent variable in the model. Values above 2 were used to indicate a multicollinearity problem in the model. The independent explanatory role of the linearly associated variables on a condition of low BMD values was verified by means of logistic regression models, by gender. The outcome binary variable was obtained by dichotomizing total hip BMD values on the gender-specific first tertile, 0.63 g/cm 2 for women and 0.83 g/cm 2 for men. Among the explanatory variables, serum albumin was dichotomized on the first decile of the sample population distribution (40 g/l), and protein daily intake on the first tertile (65.7 g/day), and BMI was divided into four classes: p22 (underweight); 22-25; 25-30; X30 (overweight). The odds ratio and 95% confidence interval (CI) of each independently associated condition were evaluated referring to clinically safe levels. The level of significance was set at 0.05 for all tests. Analyses were performed with the SAS Statistical Software Package rel. 8.2 (SAS Institute, Cary, NC, USA).
Results
General and nutritional characteristics of the study population are given in Table 1 , divided by gender. The men and women were comparable for age and BMI. Mean albuminemia values were also similar in the two sexes, while serum 25-hydroxyvitamin D was significantly lower in women. Energy and nutrient intakes, including calcium, were significantly higher in men than in women, but when the intake of macronutrients was calculated as a percentage of total calorie intake, 32% was attributed to lipids, 15% to proteins and 53% to carbohydrates in both genders. Table 2 shows the means and standard deviations for ASMM and bone mass variables, by gender. ASMM and ASMMI were significantly higher in men than in women, and so were the mean BMD, T-score and Z-score values at different femoral sites, with the women departing more from the reference distributions.
The overall prevalence of osteoporosis, sarcopenia and hypoalbuminemia in the sample population was 32.2, 49.6 and 5.7%, respectively. When the two genders were compared, osteoporosis was significantly more prevalent (Po0.0001) among women than men (44.7 vs 12.5%), whereas the proportions of sarcopenia (49.1 vs 50.4%) and hypoalbuminemia (5.9 vs 5.5%) did not differ significantly. Figure 1 shows the mean total hip BMD values of hypoalbuminemic (o40 g/l) and normo-albuminemic subjects (X40 g/l), by BMI class. In both genders, total mean BMD values rose with rising BMI ratings and were generally lower in hypoalbuminemic subjects. For women, two-way ANOVA confirmed the independent effect on mean BMD of both BMI (P ¼ 0.0001) and albumin level (P ¼ 0.01). No interaction was found, however. For men, the analysis only confirmed the effect of BMI (P ¼ 0.002).
As for the quantitative variables, linear correlation analysis (Table 3) indicated that age, BMI, serum albumin and ASMM were significantly associated with BMD at different hip sites in both genders; protein intake also correlated significantly with BMD, but only in men. None of the other nutritional variables correlated significantly with hip bone density. Table 3 shows the partial and total R 2 coefficients for the multiple linear regression models entering all the linearly associated variables, that is age, BMI, albumin, ASMM and protein intake (for men), to describe BMD at different sites, by gender. In men, BMI and protein intake maintained their independent role in predicting total hip BMD, whereas albumin and ASMM lost their significance. BMI was the only significant predictor of BMD in the neck, whereas at trochanter level BMD was significantly predicted by ASMM and protein intake. In women, only BMI and albuminemia emerged as significant independent variables in estimating BMD at all femoral sites. No collinearity effect was identified by a variance inflating factor greater than 1.7. Table 4 shows the logistic regression for estimating associations between low BMD (as an independent variable) and BMI, serum albumin and protein intake categories, by gender.
In men, a low BMI and protein intake were independently associated with the risk of a low BMD. BMI values o22 kg/m 2 Figure 1 Mean values for total hip bone mineral density by gender, body mass index (BMI) class and serum albumin level. * Two-way ANOVA: BMI and albumin are independent significant factors. ** Two-way ANOVA: BMI is an independent significant factor.
Predictors of low BMD in the elderly: the role of nutritional status and sarcopenia A Coin et al coincided with a very high risk (OR ¼ 12, 95% CI 2.1-70.0), while higher BMI classes carried no risk. A low protein intake (o65.7 g/day) corresponded to an OR of 3.7 (95% CI 1.4-9.7).
In women, the risk of a low BMD was already about five times higher in the 25-30 BMI class than in the reference class (BMI430), and up to 26 times higher in the lowest BMI class (o22). Albumin levels o40 g/l also had a significant, independent role (OR ¼ 2.6, 95% CI 1.2-5.8).
Discussion
Our study investigated the role of sarcopenia, dietary intake and nutritional status on bone mass loss in the elderly with a view to developing nutritional supplementation programs and physical activation measures for the prevention of osteoporosis. We also tested the influence of different thresholds of common nutritional predictors of a low BMD risk, that is BMI, serum albumin and protein intake. Predictors of low BMD in the elderly: the role of nutritional status and sarcopenia A Coin et al To highlight the relationship between sarcopenia, nutrition and bone mass, we excluded subjects with severe diseases and functional alterations that might represent confounding factors, particularly with advancing age.
Our study confirmed a major role for BMI in predicting BMD variability, accounting for about 30% of the variability in women and 20% in men; this confirms the well-known association between BMI and BMD based on a number of large-scale epidemiological studies (Edelstein and BarrettConnor 1993; Felson et al., 1993; Nguyen et al, 2000) . This association has been explained on the strength of biomechanical forces (Glynn et al., 1995) and a greater aromatization of androgens at subcutaneous adipose tissue level (Rebuffe-Scrive et al., 1990; Murphy et al., 1993; Vaananen and Harkonen, 1996; Slemenda et al., 1997) .
The results of logistic regression show a different genderrelated association between BMI and low BMD, while also emphasizing the importance of being underweight. In men, the risk of a low BMD is not clinically relevant down to BMI values of 22, then it increases 12-fold. In women, the risk of a low BMD rises progressively from about fivefold with a BMI of 25-30 to 26-fold in the lowest BMI (underweight) class.
This different relationship between BMI and BMD in the two genders might depend on menopausal hormone changes in women and the different role of weight load in men and women. In women, BMI values within the normalto over-weight range (BMI 22-30) may already suffice to increase the risk of a low BMD and osteoporosis by comparison with the obese (BMI430), whereas a man's bone seems to be protected against the risk of a low BMD until he becomes underweight. Men are probably less sensitive to the effect of weight load on bone in conditions of normal nutritional status, while being undernourished is an unfavorable prognostic factor in both genders. The significance of the BMI 22 threshold in both genders confirms that special attention should be paid to BMI values indicating mild underweight (considered normal by the WHO), which coincide not only with a higher mortality risk but also with a greater chance of low bone mass, frailty and fractures.
Among nutrients, energy, carbohydrate, lipid and calcium intakes were unrelated to femoral BMD. Energy intake is related to body size, physical activity and weight variations that influence BMD, which is why previous authors found significant relationship between BMD and energy intake (Ilich et al., 2003) . No such relationship appears in our study, probably due to the highly variable levels of physical activity thermogenesis in the elderly, and also to differences in body size: among subjects with the same BMI, those who are taller and heavier have a higher energy intake, but they might have the same BMD.
Protein intake was independently related to femoral BMD in men, while no such association was found in women. Protein intake seems important in maintaining bone health and minimizing bone loss in elderly people (Hannan et al., 2000) . Hip-fracture patients reportedly tend to have lowprotein and low-energy diets (Bonjour et al., 1996) . Protein supplementation has led to a reduction in femoral bone loss and shorter rehabilitation after hip fracture (Schurch et al., 1998) . Dietary improvement (Hampson et al., 2003) in elderly women with a low BMI is associated with a reduction in bone resorption and also has a slight effect on bone formation. Our results showed no association between protein intake and femoral BMD in women, probably because their nutritional status was good and because other, more important factors (hormone changes, menopause, pregnancies and lactation) influence bone mass. The 65.7 g/day protein intake threshold, corresponding to the first tertile of distribution, coincided with a fourfold risk of low BMD in well-nourished, healthy elderly. This threshold might be used in dietary assessments to identify patients with a potentially higher risk of osteoporosis. At the same time, a protein intake higher then 65.7 could be suggested in dietary measures. Considering the mean weight of our subjects, this value corresponds to about 0.8-0.9 g per kg of body weight, which comes close to the recommended daily dose (National Research Council, 1989) .
Albumin was also associated with BMD in our elderly subjects, especially in women for whom it maintains an independent effect in multiple regression. Albumin values below the tenth percentile (40 g/l) were also associated in women with a 2.5-fold risk of low BMD. Although there was no apparent association with daily protein intake, when the nutritional deficiency becomes chronic and produces mass and visceral protein depletion, the effect on bone mass loss also comes to light. Serum albumin is a sensitive indicator of severe protein depletion and some authors use it as a measure of frailty and disability (Baumgartner et al., 1996) . Serum albumin was found inversely associated with the risk of hip fracture, both in a prospective study (Thiebaud et al., 1997) and in a case-control study (Huang et al., 1996) , supporting the view that severe protein depletion plays a part in causing hip fracture (Di Monaco et al., 2003) . Conflicting results have been reported on the relationship between serum albumin and BMD, however. In our earlier study, underweight hypoalbuminemic subjects had a lower T-score than underweight cases with normal serum albumin levels (Coin et al., 2000) -findings consistent with the positive correlation demonstrated by other authors in both genders (Thiebaud et al., 1997) and in women alone (Di Monaco et al., 2003) . But two large cross-sectional studies failed to confirm this correlation between albumin and BMD (Lunde et al., 1998; D'Erasmo et al., 1999) .
Sarcopenia (physiological muscle loss) may contribute to bone mass loss, but its role may be confused with that of nonphysiological conditions such as nutritional disorders (Sergi et al 2006) . Our subjects revealed a prevalence of sarcopenia in about 50% of both men and women, but our results -like those of other authors (Walsh et al., 2006) identified no independent effect of sarcopenia (expressed by ASMM as an independent variable) on total femoral BMD. Walsh recently demonstrated that the relationship between the ASMMI, BMD and the risk of osteoporosis may be mediated largely by physical activity. Our study did not investigate physical activity, but sarcopenia lost its significant correlation with femoral BMD after adjusting for BMI and the other nutritional variables investigated. This is probably partly due to the strength of the BMI variable, which also includes muscle mass. In fact, BMI expresses nutritional status and both adipose and muscle mass deficiencies, whereas the parameter used for sarcopenia (ASMM) considers not total muscle mass, but only limb muscle mass. On the other hand, LBM (which includes all lean masses) cannot be considered because of the influence of organs and nonmuscle tissues. Further studies are needed, using different indicators of sarcopenia, such as strength and muscle function.
Our study has some limitations. The first is the lack of data on physical activity and muscle strength. All of our subjects were independent in terms of physical and instrumental activities of daily living and were able to walk at least 800 m without difficulty, suggesting a normal 'physical daily life'. We think that the relationship between LBM and BMD in these subjects may also partially express the effect of muscle strength on bone. In fact, a previous paper showed that the independent effect of muscle strength on bone diminished after adding LBM to the multiple regression analysis (Taaffe et al., 2001) . Another limit of our study could be the sampling method: although our findings are reasonable, the enrolment criteria adopted seem to limit their generalizability. On the other hand, the study seeks to contribute to our understanding of basic age-dependent changes in bone, as this is essential for preventive purposes. More general selection criteria would bring in a number of factors very likely to interfere with the relationships between BMD and the variables studied, and adjusting for these factors in the analysis would demand a much larger sample size.
In conclusion, our findings suggest that BMI expresses the relationship between nutritional status and BMD better than other nutritional indices, and that age-related sarcopenia is not involved in bone mass loss. Moreover, BMI values o22 kg/m 2 , though still within the normal range for younger adults, carry a higher risk of osteoporosis in the elderly, particularly in women.
